A Rapid Review of Potential Drug Treatments for Children with COVID-19

The paediatric population constitutes a much smaller proportion of COVID-19 patients and seems to be less severely affected. However, the massive numbers infections mean that many children require treatment in hospital. In concerted wide-ranging effort discover safe effective for COVID-19, involvement is necessary. This review aims identify leading potential drug treatments vaccines are being investigated with involved. Clinicaltrials.gov, WHO Trial Registry Platform (ICTRP) RAPS vaccine tracker webportals were searched clinical trials phase 3 involved below 15 years age. Any preliminary results released online. found 25 participants 2 trials. No findings found. Remdesivir appears candidate candidates, inactivated nCoV-19 (Sinopharm) ChAdOx1 (Oxford University), recruiting large currently licensed but from numerous eagerly awaited.